Last reviewed · How we verify
NCT04224090
Diagnostic Performance of a New Method for the Echocardiographic Assessment of Coronary Arteries Abnormalities
trial testing Echocardiographic assessment of coronary arteries origin and proximal course in Coronary Artery Anomaly in 4,000 participants. Completed in 1 December 2021.
1 December 2020
Quick facts
| Lead sponsor | ITAB - Institute for Advanced Biomedical Technologies |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,000 |
| Start date | 1 January 2014 |
| Primary completion | 1 December 2020 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Echocardiographic assessment of coronary arteries origin and proximal course
Conditions studied
- Coronary Artery Anomaly — all drugs for Coronary Artery Anomaly →
Sponsor
ITAB - Institute for Advanced Biomedical Technologies
Who can join
Eligibility, any sex, with Coronary Artery Anomaly. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coronary artery anomalies (CAA) are a rare congenital condition, accounting abnormalities of origin, course, destination, size, and number of the coronary vessels. In normal hearts, the coronary arteries, the left and right coronary arteries (LCA and RCA, respectively) originate from the two facing aortic sinuses of Valsalva, so-called left and right. To overcome the echocardiographic limitations, the investigators designed, studied and implemented in our Institute a specific echocardiographic-based two-dimensional non-Doppler 4-views approach for the diagnosis of CAA.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Echocardiographic screening for the anomalous aortic origin of coronary arteries.
Bianco F, Colaneri M, Bucciarelli V, Surace FC, et al · · 2021 · cited 10× · PMID 33431619 · DOI 10.1136/openhrt-2020-001495
Verify or expand the search:
- PubMed search for NCT04224090
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Anomaly
Currently open trials in the same condition.
- NCT06089902 — European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries · recruiting
Other ITAB - Institute for Advanced Biomedical Technologies trials
Trials by the same sponsor.
- NCT05824221 — Effect of rTMS on Neurotrophines Levels in CUD · NA · unknown
- NCT05798143 — Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression · NA · recruiting
- NCT04897295 — Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder · NA · not yet recruiting
- NCT05016479 — Accelerated rTMS in Gambling Disorder: a Multicentric, Randomized, Sham-controlled Trial · NA · unknown
- NCT04691791 — Italian Registry of Cardiovascular Magnetic Resonance on Congenital Anomalies of the Coronary Arteries (ITACA-Registry) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04224090 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ITAB - Institute for Advanced Biomedical Technologies
- Last refreshed: 24 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04224090.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing